AGGRESSIVE CHEMOTHERAPY FOR DIFFUSE HISTIOCYTIC LYMPHOMA IN THE ELDERLY - INCREASED COMPLICATIONS WITH ADVANCING AGE

被引：203
|
作者：
ARMITAGE, JO
POTTER, JF
机构：
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 1984年 / 32卷 / 04期
关键词：
D O I：
10.1111/j.1532-5415.1984.tb02020.x
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：269 / 273
页数：5
相关论文
共 50 条
  • [41] Role of anemia in survival of patients with elderly aggressive non-Hodgkin's lymphoma after chemotherapy
    Stefoni, V
    Tani, M
    Alinari, L
    Marchi, E
    Gabriele, A
    Musuraca, G
    Fina, M
    Pileri, S
    Baccarani, M
    Zinzani, PL
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 102 - 102
  • [42] Role of anemia in survival of patients with elderly aggressive non-Hodgkin's lymphoma after chemotherapy
    Zinzani, PL
    Tani, M
    Alinari, L
    Molinari, AL
    Stefoni, V
    Visani, G
    Gentilini, P
    Guardigni, L
    Fina, M
    Baccarani, M
    [J]. LEUKEMIA & LYMPHOMA, 2005, 46 (10) : 1449 - 1454
  • [43] COMBINED RADIOTHERAPY (XRT) AND CHEMOTHERAPY (CT) FOR STAGE-I AND STAGE-II DIFFUSE LARGE CELL (HISTIOCYTIC) LYMPHOMA (DICL)
    VELASQUEZ, W
    HAGEMEISTER, F
    FULLER, L
    MCLAUGHLIN, P
    CONRAD, FG
    BUTLER, JJ
    SHULLENBERGER, CC
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 523 - 523
  • [44] PHASE-III TRIAL OF VINCRISTINE (V) INFUSION IN COMBINATION CHEMOTHERAPY FOR STAGE III-IV DIFFUSE HISTIOCYTIC LYMPHOMA (DHL)
    CRAIG, J
    JACKSON, D
    POWELL, B
    ZEKAN, P
    MUSS, H
    WHITE, D
    RICHARDS, F
    SPURR, C
    CAPIZZI, R
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 192 - 192
  • [45] R-split-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma
    Kreher, Stephan
    Lammer, Felicitas
    Augustin, Dieter
    Pezzutto, Antonio
    Baldus, Claudia D.
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 93 (01) : 70 - 76
  • [46] Chemotherapy is associated with increased risk of fracture in elderly patients with non-Hodgkin's lymphoma
    Lu, H.
    Cabanillas, M.
    Fang, S.
    Du, X. L.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S316 - S317
  • [47] EFFECT OF AGE ON CAUSE OF DEATH IN PATIENTS TREATED WITH CHEMOTHERAPY FOR AGGRESSIVE NON-HODGKINS LYMPHOMA (NHL)
    VOSE, JM
    ARMITAGE, JO
    WEISENBURGER, DD
    BIERMAN, PJ
    MORAVEC, D
    HUTCHINS, M
    HOWE, D
    SORENSEN, S
    DOWLING, M
    OKERBLOOM, J
    PEVNICK, W
    PACKARD, W
    THOMPSON, J
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 211 - 211
  • [48] Pegylated liposomal doxorubicin in combination chemotherapy in the treatment of previously untreated aggressive diffuse large-B-cell lymphoma
    Avilés, A
    Neri, N
    Castañeda, C
    Talavera, A
    Huerta-Guzmán, J
    González, M
    [J]. MEDICAL ONCOLOGY, 2002, 19 (01) : 55 - 58
  • [49] Pegylated liposomal doxorubicin in combination chemotherapy in the treatment of previously untreated aggressive diffuse large-B-cell lymphoma
    Agustin Avilés
    Natividad Neri
    Claudia Castañeda
    Alejandra Talavera
    Judith Huerta-Guzmán
    Martha González
    [J]. Medical Oncology, 2002, 19 : 55 - 58
  • [50] Rituximab provides durable remission in a patient with refractory aggressive diffuse B-cell lymphoma failing salvage chemotherapy
    Robach, E
    Ustun, C
    Kallab, A
    Burgess, RE
    Jillella, AP
    [J]. LEUKEMIA & LYMPHOMA, 2002, 43 (11) : 2235 - 2236
12345